BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24300781)

  • 1. The association of anti-annexin1 antibodies with the occurrence of skin lesions in systemic lupus erythematosus.
    Meng Z; Shi ZR; Tan GZ; Yin J; Wu J; Mi XB; Wang L
    Lupus; 2014 Feb; 23(2):183-7. PubMed ID: 24300781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-high mobility group box 1 (anti-HMGB1) antibodies are not related to the occurrence of cutaneous lesions in systemic lupus erythematosus.
    Tan G; Zhu N; Shi Z; Meng Z; Yu M; Li K; Yin J; Wei K; Mi X; Wang L
    Scand J Rheumatol; 2015; 44(2):150-6. PubMed ID: 25439526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
    Pruzanski W; Goulding NJ; Flower RJ; Gladman DD; Urowitz MB; Goodman PJ; Scott KF; Vadas P
    J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
    Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
    Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
    Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
    Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
    Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
    Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
    J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
    Saxena R; Sturfelt G; Nived O; Wieslander J
    Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
    Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S
    J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
    Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
    Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
    J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients.
    Isenberg D; Dudeney C; Wojnaruska F; Bhogal BS; Rauch J; Schattner A; Naparstek Y; Duggan D
    J Immunol; 1985 Jul; 135(1):261-4. PubMed ID: 3873490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.